Skip to main content
FinSpry Logo
FinSpry
TRVI logo
TRVI
(NASDAQ)
Trevi Therapeutics, Inc.
$17.18-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Trevi Therapeutics, Inc. (TRVI) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Trevi Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 7 professional research analysts

Consensus Rating

Buy
Based on 7 unique analysts
(9 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$24.43
↑ 42.20% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest TRVI Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Serge Belanger
Needham
BuyMaintains
$23.00
Leland Gershell
Oppenheimer
BuyReiterates
$24.00
Kaveri Pohlman
Clear Street
BuyMaintains
$21.00 → $29.00
Debanjana Chatterjee
JonesTrading
BuyMaintains
$24.00
Annabel Samimy
Stifel Nicolaus
BuyReiterates
$18.00 → $30.00
Debanjana Chatterjee
JonesTrading
BuyMaintains
$24.00
Brandon Folkes
HC Wainwright
BuyReiterates
$21.00
Judah Frommer
Morgan Stanley
BuyReiterates
$18.00 → $20.00
Judah Frommer
Morgan Stanley
BuyInitiates Coverage
$18.00 → $20.00

Frequently Asked Questions

What is the analyst consensus rating for TRVI?

The analyst consensus rating for TRVI is "Buy" based on 7 analyst recommendations.

What is the average price target for TRVI?

The average 12-month price target for TRVI is $24.43, representing an upside of 42.2% from the current price of $17.18.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.